About BioLife Solutions, Inc. 
BioLife Solutions, Inc.
Pharmaceuticals & Biotechnology
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.
Company Coordinates 
Company Details
3303 Monte Villa Pkwy Ste 310 , BOTHELL WA : 98021-6200
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 64 Schemes (47.81%)
Foreign Institutions
Held by 73 Foreign Institutions (5.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Raymond Cohen
Independent Chairman of the Board
Mr. Michael Rice
President, Chief Executive Officer, Director
Mr. Andrew Hinson
Independent Director
Mr. Joseph Schick
Independent Director
Revenue and Profits:
Net Sales:
25 Million
(Quarterly Results - Jun 2025)
Net Profit:
-16 Million
Pharmaceuticals & Biotechnology
USD 1,256 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.20
-5.76%
3.62






